Federated Hermes’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $251M | Buy |
|
|||||
|
2025
Q2 | $106M | Buy |
|
|||||
|
2025
Q1 | $71.3M | Buy |
|
|||||
|
2024
Q4 | $58.7M | Buy |
|
|||||
|
2024
Q3 | $46.5M | Buy |
|
|||||
|
2024
Q2 | $22.5M | Sell |
|
|||||
|
2024
Q1 | $22.2M | Buy |
|
|||||
|
2023
Q4 | $26.3M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $771K | Sell |
|
|||||
|
2023
Q1 | $9.28M | Sell |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $168M | Buy |
|
|||||
|
2021
Q3 | $181M | Sell |
|
|||||
|
2021
Q2 | $166M | Sell |
|
|||||
|
2021
Q1 | $140M | Buy |
|
|||||
|
2020
Q4 | $95.6M | Buy |
|
|||||
|
2020
Q3 | $82M | Sell |
|
|||||
|
2020
Q2 | $85.4M | Sell |
|
|||||
|
2020
Q1 | $64.4M | Sell |
|
|||||
|
2019
Q4 | $84.6M | Buy |
|
|||||
|
2019
Q3 | $44.7M | Buy |
|
|||||
|
2019
Q2 | $33.9M | Sell |
|
|||||
|
2019
Q1 | $49.3M | Buy |
|
|||||
|
2018
Q4 | $38.4M | Sell |
|
|||||
|
2018
Q3 | $57M | Buy |
|
|||||
|
2018
Q2 | $59.4M | Buy |
|
|||||
|
2018
Q1 | $47.8M | Sell |
|
|||||
|
2017
Q4 | $79.9M | Buy |
|
|||||
|
2017
Q3 | $20.1M | Buy |
|
|||||
|
2017
Q2 | $4.97M | Buy |
|
|||||
|
2017
Q1 | $513K | Hold |
|
|||||
|
2016
Q4 | $374K | Sell |
|
|||||
|
2016
Q3 | $712K | Sell |
|
|||||
|
2016
Q2 | $586K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $17K | Buy |
|